UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intestinal bacteria associated with irritable bowel syndrome and chronic fatigue

Neurogastroenterology and motility, 2023-09, Vol.35 (9), p.e14621-n/a

El‐Salhy, Magdy

2023

Volltextzugriff (PDF)

Factors affecting the outcome of fecal microbiota transplantation for patients with irritable bowel syndrome

Neurogastroenterology and motility, 2024-01, Vol.36 (1), p.e14641-n/a

2024

Volltextzugriff (PDF)

Letter: A step forward towards a standard FMT protocol for IBS

Alimentary pharmacology & therapeutics, 2023-11, Vol.58 (10), p.1115-1116

2023

Volltextzugriff (PDF)

Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome

Neurogastroenterology and motility, 2021-02, Vol.33 (2), p.e13983-n/a

2021

Volltextzugriff (PDF)

Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation

Neurogastroenterology and motility, 2022-09, Vol.34 (9), p.e14353-n/a

2022

Volltextzugriff (PDF)

Long‐term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome

Neurogastroenterology and motility, 2022-01, Vol.34 (1), p.e14200-n/a

2022

Volltextzugriff (PDF)

Letter: faecal microbiota transplantation for irritable bowel syndrome—which improvements are required?

Alimentary pharmacology & therapeutics, 2020-12, Vol.52 (11-12), p.1752-1753

2020

Volltextzugriff (PDF)

Density of Musashi‑1‑positive stem cells in the stomach of patients with irritable bowel syndrome

Molecular medicine reports, 2020-10, Vol.22 (4), p.3135-3140

2020

Volltextzugriff (PDF)

Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting

Molecular medicine reports, 2019-07, Vol.20 (1), p.787-794

2019

Volltextzugriff (PDF)

Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones

Nutrients, 2019-08, Vol.11 (8), p.1824

2019

Volltextzugriff (PDF)

Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome

Experimental and therapeutic medicine, 2016-09, Vol.12 (3), p.1398-1404

2016

Volltextzugriff (PDF)

Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS)

Nutrients, 2019-06, Vol.11 (6), p.1415

2019

Volltextzugriff (PDF)

Increased Chromogranin A Cell Density in the Large Intestine of Patients with Irritable Bowel Syndrome after Receiving Dietary Guidance

Gastroenterology research and practice, 2015-01, Vol.2015 (2015), p.1-8

2015

Volltextzugriff (PDF)

The role of the neuropeptide Y (NPY) family in the pathophysiology of inflammatory bowel disease (IBD)

Neuropeptides (Edinburgh), 2016-02, Vol.55, p.137-144

2016

Volltextzugriff (PDF)

The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation

PloS one, 2018-11, Vol.13 (11), p.e0194904-e0194904

2018

Volltextzugriff (PDF)

Duodenal Chromogranin A Cell Density as a Biomarker for the Diagnosis of Irritable Bowel Syndrome

Gastroenterology research and practice, 2014-01, Vol.2014 (2014), p.1-8

2014

Volltextzugriff (PDF)

Is irritable bowel syndrome an organic disorder?

World journal of gastroenterology : WJG, 2014-01, Vol.20 (2), p.384-400

2014

Volltextzugriff (PDF)

Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome

Molecular medicine reports, 2014-11, Vol.10 (5), p.2322-2326

2014

Volltextzugriff (PDF)

Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities

World journal of gastroenterology : WJG, 2015-08, Vol.21 (32), p.9577-9587

2015

Volltextzugriff (PDF)

Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome

BMC gastroenterology, 2017-08, Vol.17 (1), p.90-90, Article 90

2017

Volltextzugriff (PDF)

The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome

Frontiers in cellular and infection microbiology, 2021-05, Vol.11, p.524851-524851

2021

Volltextzugriff (PDF)

Changes in enteroendocrine and immune cells following colitis induction by TNBS in rats

Molecular medicine reports, 2016-12, Vol.14 (6), p.4967-4974

2016

Volltextzugriff (PDF)

Endocrine cells in the ileum of patients with irritable bowel syndrome

World journal of gastroenterology : WJG, 2014-03, Vol.20 (9), p.2383-2391

2014

Volltextzugriff (PDF)

Chromogranin A Cell Density as a Diagnostic Marker for Lymphocytic Colitis

Digestive diseases and sciences, 2012-12, Vol.57 (12), p.3154-3159

2012

Volltextzugriff (PDF)

Inhibition of Cellular and Animal Inflammatory Disease Models by NF-κB Inhibitor DHMEQ

Cells (Basel, Switzerland), 2021-09, Vol.10 (9), p.2271

2021

Volltextzugriff (PDF)

1 – 25 von 189

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(156)
Mit Volltextzugriff
(139)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intestinal bacteria associated with irritable bowel syndrome and chronic fatigue

Factors affecting the outcome of fecal microbiota transplantation for patients with irritable bowel syndrome

Letter: A step forward towards a standard FMT protocol for IBS

Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome

Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation

Long‐term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome

Letter: faecal microbiota transplantation for irritable bowel syndrome—which improvements are required?

Density of Musashi‑1‑positive stem cells in the stomach of patients with irritable bowel syndrome

Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting

Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones

Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome

Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS)

Increased Chromogranin A Cell Density in the Large Intestine of Patients with Irritable Bowel Syndrome after Receiving Dietary Guidance

The role of the neuropeptide Y (NPY) family in the pathophysiology of inflammatory bowel disease (IBD)

The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation

Duodenal Chromogranin A Cell Density as a Biomarker for the Diagnosis of Irritable Bowel Syndrome

Is irritable bowel syndrome an organic disorder?

Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome

Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities

Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome

The Effects of Fecal Microbiota Transplantation on the Symptoms and the Duodenal Neurogenin 3, Musashi 1, and Enteroendocrine Cells in Patients With Diarrhea-Predominant Irritable Bowel Syndrome

Changes in enteroendocrine and immune cells following colitis induction by TNBS in rats

Endocrine cells in the ileum of patients with irritable bowel syndrome

Chromogranin A Cell Density as a Diagnostic Marker for Lymphocytic Colitis

Inhibition of Cellular and Animal Inflammatory Disease Models by NF-κB Inhibitor DHMEQ

Suchergebnisse filtern